Oral Stent Device for Radiation Treatments of Oral Cancers

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to examine that ability of the experimental oral stent device to reduce the volume of mandible receiving >55 Gy by 50%during radiation treatment as assessed duri radiation treatment planning. Patients will have CT scans at three time-points during their standard of care radiation treatment. During these visits patients will receive scans via CT or cone beam CT scan, with both the standard and experimental oral stent devices. During radiation treatment patients will receive the standard oral stent device.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04041141
Study type	Observational
Source	Indiana University
Contact
Status	Withdrawn
Phase
Start date	September 25, 2019
Completion date	February 3, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01469429` - Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.	Phase 1/Phase 2
Completed	`NCT00049283` - Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer	Phase 1
Completed	`NCT00407810` - Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer	Phase 2
Completed	`NCT00096512` - S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer	Phase 2
Completed	`NCT01637194` - Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer	Phase 1
Completed	`NCT00033618` - Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck	Phase 2
Completed	`NCT01816841` - Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care	N/A
Recruiting	`NCT04028479` - The Registry of Oncology Outcomes Associated With Testing and Treatment
Completed	`NCT04059861` - Ultrasound in Tongue Cancer- a Help to Decide Depth of Invasion and to Improve the Surgical Margin	N/A
Recruiting	`NCT01854021` - Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer	N/A
Completed	`NCT01816984` - PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer	Phase 1/Phase 2
Withdrawn	`NCT01674374` - Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy	Phase 2
Terminated	`NCT01528137` - Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer	Phase 1
Completed	`NCT04337853` - Radiotherapy of Tongue Cancer Using an Intraoral Stent	Phase 1
Completed	`NCT01806675` - 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy	Phase 1/Phase 2
Active, not recruiting	`NCT01847326` - Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer	Phase 1
Terminated	`NCT02177838` - Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer	N/A
Completed	`NCT00114283` - Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer	Phase 2
Completed	`NCT04126226` - Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech Therapy	N/A
Completed	`NCT00293462` - GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer	Phase 3